Antibody-Drug Conjugates

Discover the groundbreaking insights in "Antibody-Drug Conjugates" by Kenneth J. Olivier, published by John Wiley & Sons Inc in 2016. This comprehensive hardback edition spans 560 pages and serves as an essential resource for anyone involved in immunopharmacology. The book delves into practical and proven strategies for successful antibody-drug conjugate (ADC) drug discovery in oncology. Readers will gain valuable knowledge on enhancing the safety and therapeutic efficacy of ADCs, specifically designed to target and eliminate tumor cells effectively. Whether you are a researcher, clinician, or student, this book will equip you with the tools needed to navigate the complexities of ADC development and improve patient outcomes in cancer treatment. Don’t miss the opportunity to elevate your understanding of this innovative approach in modern medicine.